Inhibitor of human plasma kallikrein DX-88 for the treatment of acute attack in a family with hereditary angioedema

被引：0
|
作者：
Anne, R
Deveras, E
Bracho, F
机构：
[1] Georgetown Univ Hosp, Div Hematol Oncol, Washington, DC 20007 USA
[2] Georgetown Univ Hosp, Div Pediat Hematol Oncol, Washington, DC 20007 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4109
引用
收藏
页码：113B / 114B
页数：2
相关论文
共 50 条
  • [31] Subcutaneous DX-88 (ecallantide) for the treatment of acute attacks of hereditary angioedema: results from the pivotal phase 3, double-blind, placebo-controlled EDEMA4 trial
    Levy, R.
    Lumry, W.
    McNeil, D.
    Li, H.
    Horn, P.
    Pullman, W.
    [J]. ALLERGY, 2009, 64 : 120 - 121
  • [32] C1 Esterase Inhibitor (Human) for the Treatment of Acute Hereditary Angioedema
    Rodrigues Valle, Solange Oliveira
    Franca, Alfeu Tavares
    Campos, Regis A.
    Grumach, Anete Sevciovic
    [J]. CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2011, 4 : 421 - 430
  • [33] Treatment of an acute attack of type III hereditary angioedema with ecallantide
    Cronin, Julia A.
    Maples, Kelly M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (01) : 61 - 62
  • [34] Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
    Zuraw, Bruce
    Cicardi, Marco
    Levy, Robyn J.
    Nuijens, Jan H.
    Relan, Anurag
    Visscher, Sonja
    Haase, Gerald
    Kaufman, Leonard
    Hack, C. Erik
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (04) : 821 - U229
  • [35] Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema
    Duckworth, Edward J.
    Murugesan, Nivetha
    Li, Lily
    Rushbrooke, Louise J.
    Lee, Daniel K.
    De Donatis, Gian Marco
    Maetzel, Andreas
    Yea, Christopher M.
    Hampton, Sally L.
    Feener, Edward P.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (09): : 1059 - 1070
  • [36] Use of recombinant plasma kallikrein inhibitor in hereditary angioedema: A case report and review of the management of the disorder
    Turner, MD
    Ougbourli, A
    Heaney, K
    Selvaggi, T
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (12) : 1553 - 1556
  • [37] Plasma kallikrein activation in patients with hereditary angioedema due to C1 inhibitor deficiency
    Zanichelli, A.
    Maggioni, L.
    Cicardi, M.
    [J]. ALLERGY, 2009, 64 : 571 - 572
  • [38] TREATMENT OF LIFE-THREATENING ANGIOEDEMA WITH PURIFIED KALLIKREIN INHIBITOR AND WITH FRESH PLASMA
    BAHRAMBEYGUI, G
    REID, RT
    [J]. JOURNAL OF ALLERGY, 1971, 47 (02): : 103 - +
  • [39] Recombinant and Plasma-Purified Human C1 Inhibitor for the Treatment of Hereditary Angioedema
    Frank, Michael M.
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2010, 3 : S29 - S33
  • [40] STAR-0215 is a Novel, Long-Acting Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Potential Treatment of Hereditary Angioedema
    Bedian, Vahe
    Biris, Nikolaos
    Omer, Charles
    Chung, Jou-Ku
    Fuller, James
    Dagher, Rafif
    Chandran, Sachin
    Harwin, Peter
    Kiselak, Tomas
    Violin, Jonathan
    Nichols, Andrew
    Quellis, Pradeep Bista
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 387 (02): : 214 - 225
12345